more

Alnylam Pharmaceuticals (ALNY)

Name: Alnylam Pharmaceuticals (ALNY) Earnings Announcement
Start: NA
End: NA

(Real Time Quote from BATS)

$229.23 USD

-2.36 (-1.02%)

Updated Jan 27, 2023 01:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.28%
2	Buy	17.83%
3	Hold	9.19%
4	Sell	5.00%
5	Strong Sell	2.16%
S&P	500	10.51%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

Top 33% (83 out of 249)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Trades from $1

Fundamental Charts

Research for ALNY

Return on Equity (TTM)

About Return on Equity (TTM)

Alnylam Pharmaceuticals, Inc.'s return on equity, or ROE, is -430.74% compared to the ROE of the Medical - Biomedical and Genetics industry of -54.50%. While this shows that ALNY has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.

Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.